Paul Andrea
SEC CIK 1863130 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | GC | 1.08M | — | $60.8K | 5 | 2023-02-01 | 2025-02-03 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Paul Andrea made no open-market trades at ZNTL in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Paul Andrea | CLO | A - Grant | $0.00 | +934.0K | 1.08M | +623% | $0 |
| D | 2025-02-05 | 2025-02-03 | ZNTL | Zentalis Pharmaceuticals, Inc. | Paul Andrea | CLO | S - Sale | $1.71 | -13.2K | 1.07M | -1% | -$22.6K |
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Paul Andrea | CLO | A - Grant | $0.00 | +112.5K | 153.3K | +276% | $0 |
| D | 2024-02-05 | 2024-02-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Paul Andrea | CLO | S - Sale | $11.54 | -3,310 | 150.0K | -2% | -$38.2K |
| D | 2023-02-01 | 2023-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Paul Andrea | GC | A - Grant | $0.00 | +40.8K | 40.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations